Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Government of Canada partners with digital industries to invest in groundbreaking technology and businesses

Published

5 years ago

on

Reading Time: 4 minutes

 

The Government of Canada is building the foundation for Canadian innovators to invest, strengthen communities, grow our economy and create good middle-class jobs. The Government is partnering with groundbreaking digital industries to invest in quantum-related technologies and skills development. This will mean smarter security systems to better protect Canadians’ homes, more powerful digital security tools to secure their online transactions, and more efficient medicines to improve their health.

Today, the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), announced a total investment of $41 million in one Waterloo-based not-for-profit and three start-up companies developing cutting-edge products that integrate quantum, artificial intelligence and machine learning technologies. The total cost of the projects is $101.8 million.

Together, these investments will help create up to 167 new skilled jobs and maintain 75 jobs in Waterloo. The companies will increase their investments in research and development and strengthen their collaborations with post-secondary institutions to help drive the growth of a vibrant and world-leading Canadian quantum ecosystem.

The four investments include:

  • $20 million for the Quantum Valley Ideas Lab (QVIL), a non-profit charitable organization, to develop a unique facility that will create new quantum-related products and businesses. This project will allow Ideas Lab to establish dedicated teams of quantum researchers, engineers and technology experts. These teams will develop new innovations in the areas of quantum sensors, navigation, security, encryption and computing. These innovations will attract new companies to the Waterloo region and help some of those already there scale up and grow. QVIL’s project is valued at $43.4 million.
  • $7.3 million for Cognitive Systems to develop the next generation of its patented WiFi Motion™ software, technology that uses the home’s Wi-Fi network to identify and localize motion for the security, smart home and wellness monitoring markets. Cognitive’s project will integrate artificial intelligence into its software while expanding its technology across a wider range of devices that aim to help protect Canadian homes and residents. Cognitive’s project is valued at $25.1 million.
  • $6.5 million for High Q Technologies to develop new quantum technologies that will enable potentially life-saving treatments for illnesses, such as cystic fibrosis. The project will leverage recent advances in quantum technology to develop new and improved medical devices that will allow researchers to study diseases and pharmaceutical companies to produce new medicines more efficiently. High Q’s project is valued at $17.6 million.
  • $7.2 million for ISARA Corporation to develop new approaches to quantum-safe security to protect mission-critical data, IT infrastructure and networks today and in the quantum age. Because future large-scale quantum computers will be able to easily break existing encryption methods, the project will enable the development of practical, standardized quantum-safe encryption tools and solutions that large enterprises (such as financial institutions and governments) can easily implement using their existing systems. ISARA’s project is valued at $15.7 million.

Quotes

“Our government is partnering with Canadians to invest, grow and succeed in the global economy. We are champions of the groundbreaking work being conducted in the labs and start-ups of the Kitchener–Waterloo region. Today’s investment in the Quantum Valley will create and support hundreds of good jobs and help develop new technologies that will improve the lives of Canadians.” 
– The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development

“What we have right here in the Waterloo region is what our government is looking to foster across the country through our Innovation and Skills Plan. Like this region’s investors, entrepreneurs and collaborators, our government is committed to promoting innovation throughout the economy and encouraging inclusive growth. That’s why we’re thrilled to invest in Waterloo’s growing Quantum Valley and all the jobs and opportunities it’s creating here in our community.” 
– The Honourable Bardish Chagger, Leader of the Government in the House of Commons and Member of Parliament for Waterloo

“Simply put, quantum mechanics allows us to do things that are impossible under classical rules. Our vision for the Quantum Valley was not only to build state-of-the-art Canadian labs with world-class researchers that can develop new and transformative quantum technologies but also to help establish and grow exciting new Canadian businesses that will take these technologies to global markets. To me, it’s all about people. Attract and retain the most promising people and enable their success and big things will happen.”  
–Mike Lazaridis, O.C., O.Ont., FRS, FRSC, Co-Founder and Managing Partner, Quantum Valley Investments

Quick facts

  • Quantum technology is a new field of physics and engineering related to the energy levels of atoms and subatomic particles. Its application in technology has the potential to make a vast range of electronics smaller and faster.
  • The investment in the Quantum Valley Ideas Lab, through FedDev Ontario, is supporting the development of a world-leading ecosystem that partners with industry to create transformative, market-ready quantum technologies, reinforcing Canada’s leadership position in the global quantum revolution. Ideas Lab was founded in 2015 with a $20-million commitment from Mike Lazaridis and Doug Fregin.
  • Cognitive, High Q and ISARA are all financially backed by Quantum Valley Investments, a venture capital firm aiming to position Waterloo as a world leader in quantum technologies. Additionally, ISARA received $13 millionfrom Shasta Ventures, a Silicon Valley venture capital firm that invests in early-stage companies.
  • The investments in Cognitive, High Q and ISARA are through the Strategic Innovation Fund, a program designed to attract and support high-quality business investments in Canada’s most dynamic and innovative sectors.
  • In addition to the Strategic Innovation Fund, there are hundreds of programs and services to help businesses innovate, create jobs and grow Canada’s economy. With its simple, story-based user interface, the Innovation Canada platform can match businesses with the most fitting programs and services in about two minutes.

 

SOURCE Innovation, Science and Economic Development Canada

Related Topics:
Continue Reading

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

2 weeks ago

on

April 5, 2024

By

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

2 weeks ago

on

April 5, 2024

By

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

2 weeks ago

on

April 5, 2024

By

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending